Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes
José A. Luchsinger(Columbia University Irving Medical Center), Erica Gonzalez, Peter W.F. Wilson(VA Tennessee Valley Healthcare System), April Ross, Louise Savoye, Joshua I. Barzilay(Kaiser Permanente), Janet Brown-Friday(Albert Einstein College of Medicine), Naji Younes(George Washington University), Maxine Maher-Albertelli, Jill P. Crandall(Albert Einstein College of Medicine), Leah Holloway, Entila Xhori, Rodica Pop‐Busui(University of Michigan), Keisha Ballentine-Cargill, Julie Costello, Ashok Balasubramanyam, Colleen E. Suratt(Milken Institute), Sally Duran, Mabil Sibymon, Ruchi Gaba, Andrea Waltje(University of Michigan), Basma N. Fattaleh(University of Puget Sound), Hermes Flórez(Medical University of South Carolina), M. Diane McKee(Albert Einstein College of Medicine), Chona Gullett, Saranjit Person, Tasha Stephanie Raines, Elizabeth Burgess, Thomas W. Martens(Park Nicollet Clinic), Jeffrey S. Gonzalez(Albert Einstein College of Medicine), Samuel P. Rosin(Milken Institute), Cynthia Adams, Sridhar Tanukonda, Lawrence S. Phillips(Emory University), Mary K. Rhee(Atlanta VA Health Care System), Susana Gonzalez de la torre, Jennifer Lukin, Priscilla Hollander, H. Estrella, Folayan Morehead, Sophia H. Hox(VA Pacific Islands Health Care System), Radhika Mungara, Melissa S. Lee(State University of New York), Elizabeth R. Seaquist(Diabetes Care Center), Stephanie Beringher-Massera(Group for the Analysis of Development), Johanna Boers(Group for the Analysis of Development), Darin E. Olson(Emory University), Shihchen Kuo(Michigan Medicine), CarolAnn White(Group for the Analysis of Development), Erin J. Kazemi(Milken Institute)
Cited by 10
Related Papers
Prediction of Coronary Heart Disease Using Risk Factor Categories
|Circulation|1998|9.6k
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
|Circulation|2003|3.8k
Obesity and the Risk of Heart Failure
|New England Journal of Medicine|2002|3k
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.
|PubMed|1986|2.3k
Cardiovascular disease risk profiles
|American Heart Journal|1991|2.2k